Fed. Circ. Ruling May Reshape Hatch-Waxman Litigation Map
Patent litigation over generic drugs, which has long been concentrated in Delaware and New Jersey, may spread out to more states across the country as a result of a recent Federal...To view the full article, register now.
Already a subscriber? Click here to view full article